vs

Side-by-side financial comparison of CNO Financial Group, Inc. (CNO) and Legence Corp. (LGN). Click either name above to swap in a different company.

CNO Financial Group, Inc. is the larger business by last-quarter revenue ($1.1B vs $708.0M, roughly 1.6× Legence Corp.). CNO Financial Group, Inc. runs the higher net margin — 8.8% vs -0.1%, a 8.9% gap on every dollar of revenue. On growth, Legence Corp. posted the faster year-over-year revenue change (26.2% vs 4.2%).

CNO Financial Group, Inc., formerly Conseco, Inc., is an American financial services holding company based in Carmel, Indiana. Its insurance subsidiaries provide life insurance, annuity and supplemental health insurance products to more than four million customers in the United States. These products are distributed through independent agents, career agents and direct to customers through television advertising and direct mail.

Legence Corp is a leading sustainable building and decarbonization solution provider. It delivers energy efficiency optimization, building automation design, renewable energy integration, and low-carbon retrofit services for commercial, industrial, and institutional clients, with core operations across North America to help customers cut costs and reduce carbon footprints.

CNO vs LGN — Head-to-Head

Bigger by revenue
CNO
CNO
1.6× larger
CNO
$1.1B
$708.0M
LGN
Growing faster (revenue YoY)
LGN
LGN
+22.1% gap
LGN
26.2%
4.2%
CNO
Higher net margin
CNO
CNO
8.9% more per $
CNO
8.8%
-0.1%
LGN

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
CNO
CNO
LGN
LGN
Revenue
$1.1B
$708.0M
Net Profit
$100.7M
$-576.0K
Gross Margin
20.9%
Operating Margin
15.2%
5.3%
Net Margin
8.8%
-0.1%
Revenue YoY
4.2%
26.2%
Net Profit YoY
-39.4%
46.8%
EPS (diluted)
$1.02
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CNO
CNO
LGN
LGN
Q4 25
$1.1B
Q3 25
$1.2B
$708.0M
Q2 25
$1.2B
Q1 25
$1.0B
Q4 24
$1.1B
Q3 24
$1.1B
$560.8M
Q2 24
$1.1B
Q1 24
$1.2B
Net Profit
CNO
CNO
LGN
LGN
Q4 25
$100.7M
Q3 25
$23.1M
$-576.0K
Q2 25
$91.8M
Q1 25
$13.7M
Q4 24
$166.1M
Q3 24
$9.3M
$-1.1M
Q2 24
$116.3M
Q1 24
$112.3M
Gross Margin
CNO
CNO
LGN
LGN
Q4 25
Q3 25
20.9%
Q2 25
Q1 25
Q4 24
Q3 24
21.1%
Q2 24
Q1 24
Operating Margin
CNO
CNO
LGN
LGN
Q4 25
15.2%
Q3 25
13.7%
5.3%
Q2 25
9.8%
Q1 25
10.4%
Q4 24
15.8%
Q3 24
13.6%
4.8%
Q2 24
13.9%
Q1 24
6.5%
Net Margin
CNO
CNO
LGN
LGN
Q4 25
8.8%
Q3 25
1.9%
-0.1%
Q2 25
8.0%
Q1 25
1.4%
Q4 24
15.1%
Q3 24
0.8%
-0.2%
Q2 24
10.9%
Q1 24
9.7%
EPS (diluted)
CNO
CNO
LGN
LGN
Q4 25
$1.02
Q3 25
$0.24
$-0.02
Q2 25
$0.91
Q1 25
$0.13
Q4 24
$1.58
Q3 24
$0.09
Q2 24
$1.06
Q1 24
$1.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CNO
CNO
LGN
LGN
Cash + ST InvestmentsLiquidity on hand
$176.0M
Total DebtLower is stronger
$812.6M
Stockholders' EquityBook value
$2.6B
$387.9M
Total Assets
$38.8B
$2.6B
Debt / EquityLower = less leverage
2.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CNO
CNO
LGN
LGN
Q4 25
Q3 25
$176.0M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Total Debt
CNO
CNO
LGN
LGN
Q4 25
Q3 25
$812.6M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CNO
CNO
LGN
LGN
Q4 25
$2.6B
Q3 25
$2.6B
$387.9M
Q2 25
$2.5B
Q1 25
$2.5B
Q4 24
$2.5B
Q3 24
$2.7B
Q2 24
$2.4B
Q1 24
$2.4B
Total Assets
CNO
CNO
LGN
LGN
Q4 25
$38.8B
Q3 25
$38.3B
$2.6B
Q2 25
$37.3B
Q1 25
$37.4B
Q4 24
$37.9B
Q3 24
$37.6B
Q2 24
$36.3B
Q1 24
$34.9B
Debt / Equity
CNO
CNO
LGN
LGN
Q4 25
Q3 25
2.10×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CNO
CNO
LGN
LGN
Operating Cash FlowLast quarter
$195.7M
$162.1M
Free Cash FlowOCF − Capex
$137.4M
FCF MarginFCF / Revenue
19.4%
Capex IntensityCapex / Revenue
3.5%
Cash ConversionOCF / Net Profit
1.94×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CNO
CNO
LGN
LGN
Q4 25
$195.7M
Q3 25
$197.8M
$162.1M
Q2 25
$145.5M
Q1 25
$136.7M
Q4 24
$191.0M
Q3 24
$231.2M
Q2 24
$110.9M
Q1 24
$94.6M
Free Cash Flow
CNO
CNO
LGN
LGN
Q4 25
Q3 25
$137.4M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
CNO
CNO
LGN
LGN
Q4 25
Q3 25
19.4%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
CNO
CNO
LGN
LGN
Q4 25
Q3 25
3.5%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Cash Conversion
CNO
CNO
LGN
LGN
Q4 25
1.94×
Q3 25
8.56×
Q2 25
1.58×
Q1 25
9.98×
Q4 24
1.15×
Q3 24
24.86×
Q2 24
0.95×
Q1 24
0.84×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CNO
CNO

Health Insurance Product Line$496.4M43%
Life Insurance Segment$268.8M24%
Other$207.2M18%
Life And Annuity Insurance Product Line$170.7M15%

LGN
LGN

Installation And Fabrication$408.7M58%
Engineering And Design$110.9M16%
Program And Project Management$101.2M14%
Maintenance And Service$87.1M12%

Related Comparisons